Results

Total Results: 635 records

Showing results for "topical treatment".

61. Recommendation: Chronic Obstructive Pulmonary Disease: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/chronic-obstructive-pulmonary-disease-screening
    May 10, 2022 - to stop smoking. 12 Pharmacologic therapies (eg, bronchodilators and anti-inflammatory therapies) … and nonpharmacologic therapies (eg, interventions addressing self-management of disease, diet, exercise … (LABAs), long-acting muscarinic antagonists (LAMAs), inhaled corticosteroids (ICS), or combination therapy … cardiovascular risk association with LABAs or LAMAs was absent, or even reduced, with prevalent use of inhaled therapy … The USPSTF describes the benefits and harms of pharmacologic and nonpharmacologic COPD treatments in

62. 12th Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/2022-annual-report-to-congress.pdf
    January 01, 2022 - Evaluate data on the effects of lifestyle interventions and medical treatments for screen- detected prediabetes … and Type 2 Diabetes in Adults • Evaluate data on the effects of lifestyle interventions and medical treatments … • Evaluate data on the effects of lifestyle interventions and medical treatments for screen-detected … patients with deficient water fluoridation (<0.6 parts fluoride per million parts water [ppm F]).37-39 Topical … Cardiovascular Disease Counseling to Promote a Healthy Lifestyle in Adults Without CVD Risk Factors Hormone Therapy

63. High-Priority Evidence Gaps for Clinical Preventive Services Improving the Health of Women Through Research (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/2015annlrpt%20(4)_0.pdf
    January 01, 2016 - cascade of additional follow-up tests (some of which are invasive and could cause harm) and unnecessary treatments … Potential harms also include side effects or complications of treatments. … Effectiveness of tailored therapies in people at high risk 3. … Studies of high risk persons may help determine whether tailored therapies are more effective in these … Ophthalmia Neonatorum: Preventive Medication for Newborns The USPSTF recommends prophylactic ocular topical

64. High-Priority Evidence Gaps for Clinical Preventive Services Improving the Health of Women Through Research (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/2015annlrpt%20(4).pdf
    January 01, 2016 - cascade of additional follow-up tests (some of which are invasive and could cause harm) and unnecessary treatments … Potential harms also include side effects or complications of treatments. … Effectiveness of tailored therapies in people at high risk 3. … Studies of high risk persons may help determine whether tailored therapies are more effective in these … Ophthalmia Neonatorum: Preventive Medication for Newborns The USPSTF recommends prophylactic ocular topical

65. Archived: Final Research Plan: Impaired Visual Acuity in Older Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan93/impaired-visual-acuity-in-older-adults-screening-2016
    September 27, 2014 - Does treatment of early impairment in visual acuity due to uncorrected refractive error, cataracts, or … aids, photorefractive surgery (LASIK, LASEK, PRK), cataract surgery, vitamins and antioxidants, laser therapy … , photodynamic therapy, vascular endothelial growth factor inhibitors KQs 1, 2: Vision screening … with no treatment (including sham injection). … (falls and fractures), and it was clarified that cataract surgery is an included treatment intervention

66. Final Research Plan: Enhanced Risk Assessment for Cardiovascular Disease: Coronary Artery Calcium Scoring | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/cardiovascular-disease-enhanced-risk-assessment-non-traditional-risk-factors
    September 26, 2024 - Does treatment guided by coronary artery calcium scoring lead to improved health outcomes? … What are the harms of treatment guided by coronary artery calcium scoring? … We will also analyze benefits and harms of treatment interventions by specific populations to the extent … (e.g., PREVENT, PCE) Usual care or no screening (KQs 1 and 3 only) KQs 4, 5: Usual care, no treatment … and decision-making outcomes (e.g., prescribing and adherence to preventive cardiovascular disease treatments

67. Archived: Latent Tuberculosis Infection: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/latent-tuberculosis-infection-screening-september-2016
    September 06, 2016 - Treatment and Interventions The CDC provides recommendations for the treatment of LTBI at www.cdc.gov … /tb/topic/treatment/ltbi.htm . … group or rifapentine plus isoniazid with isoniazid alone and found that the combination therapy was noninferior … Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up … Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis

68. Archived: Final Research Plan: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan98/statin-use-in-adults-preventive-medication-november-2016
    May 02, 2014 - (e.g., statins) and lifestyle interventions (e.g., exercise and diet changes) Other types of treatments … not listed as included Treatment comparator No treatment or usual care Other comparators … or usual care without statin KQ 2: Placebo KQ 3: Higher vs. lower-potency statin therapy … In response to public comments, a key question on how benefits and harms vary according to statin therapy … lifetime cardiovascular risk will also be considered as a potential factor to determine who benefits from therapy

69. Eighth Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/usptf-annual-report-congress-2018%20(1).pdf
    January 01, 2018 - identifying tools that can accurately assess people’s risk for a specific disease; and the effectiveness of treatments … Ophthalmia Neonatorum: Preventive Medication in Newborns The USPSTF recommends prophylactic ocular topical … Considerations for Implementation: To determine whether a patient is a candidate for statin therapy, … Considerations for Implementation: To determine whether a patient is a candidate for statin therapy, … D Hormone Therapy With Combined Estrogen and Progestin in Postmenopausal Women: Primary Prevention

70. Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Reaffirmation Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/mggnaKHr496c8QCgHe9-tm
    May 01, 2021 - to stop smoking.12 Pharmacologic therapies (eg, bronchodilators and anti- inflammatory therapies) and … nonpharmacologic therapies (eg, in- terventions addressing self-management of disease, diet, exer- cise … LABAs), long-acting muscarinic an- tagonists (LAMAs), inhaled corticosteroids (ICS), or combination therapy … cardiovascular risk association with LABAs or LAMAs was absent, or even reduced, with prevalent use of inhaled therapy … The USPSTF describes the benefits and harms of pharmacologic and nonpharmacologic COPD treatments in

71. Recommendation: Genital Herpes Infection: Serologic Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/genital-herpes-serologic-screening
    February 14, 2023 - helpful, and repeat serologic testing may be indicated. 4 In symptomatic pregnant persons, antiviral therapy … Sexually transmitted infections treatment guidelines, 2021: genital herpes. … https://www.cdc.gov/std/treatment-guidelines/herpes.htm 4. … Sexually transmitted infections treatment guidelines, 2021. … https://www.cdc.gov/std/treatment/SexualHistory.htm 16.

72. Nominate a Recommendation Statement Topic | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/public-comments-and-nominations/nominate-recommendation-statement-topic
    April 01, 2019 - including direct harms (such as harms from invasive procedures), and harms from follow-up testing or treatments

73. Update on Methods: Insufficient Evidence | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/update-methods-insufficient-evidence
    March 04, 2021 - delivery in a "gold-standard" RCT may eliminate the contextual aspects of the treatment experience and … the adaptation of treatment to individual needs that underlies treatment success. … Requiring a no-treatment or usual-treatment control condition may produce insurmountable barriers to … of the clinician-patient relationship with respect to building trust and developing a collaborative therapeutic … prevents, the burdens of the therapy, the monetary costs of the therapy, and the guideline developers

74. Serological Screening for Genital Herpes: A Reaffirmation Evidence Update for the U.S. Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/XW6XUe2wRmkM-6Rrbn_462
    February 01, 2023 - This decision was based on the applicability of the populations, testing strategies, treatments, and … that are not FDA approved and are currently unavailable in the United States, such as studies of topical … Patients with recurrent genital herpes may benefit from supportive therapy alone, episodic treatment … "antiviral drug*"[tiab] OR therapy[tiab] OR "antiviral treatment"[tiab] OR "antiviral agent*"[tiab] … Devanand Antiviral therapy: Valacyclovir Treatment of Alzheimer's Disease (VALAD) Trial U.S

75. PII: S0749-3797(01)00261-6 (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/Harris2001.pdf
    January 01, 2001 - Often, compelling evidence that screening tests and treatments can reduce morbidity and mortality comes … and 2) uses a graphical format to make explicit the populations, preventive services, di- agnostic or therapeutic … (b) How do the efficacy and effectiveness of treatments compare in community settings? … Even when good randomized trials of therapeutic efficacy in asymptomatic patients exist (e.g., therapy … How to use an article about therapy or prevention. A. Are the results of the study valid?

76. Recommendation: Latent Tuberculosis Infection in Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/latent-tuberculosis-infection-screening
    May 02, 2023 - Treatment Several antibiotics are available for the treatment of LTBI. … isoniazid monotherapy, CDC-recommended regimens can be self-administered, including once-weekly combination therapy … Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up … Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis … The primary harm of treatment is hepatotoxicity.

77. Archived: Final Research Plan: Lipid Disorders in Children and Adolescents: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan151/lipid-disorders-in-children-screening-july-2016
    January 15, 2015 - A subsequent branch leads to treatment (medications, lifestyle modifications), and an arrow from treatment … Treatment and outcomes are the same as in the first analytic framework. … Does initiation of statin treatment of familial hypercholesterolemia in childhood or adolescence result … selective screening strategy KQs 1–4: Genetic screening alone Cascade screening Treatments … based on body mass index) KQs 1–4: Genetic screening alone Cascade screening Treatments

78. Second Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2012%20(2).pdf
    November 01, 2012 - cascade of additional follow-up tests (some of which are invasive and could cause harm) and unnecessary treatments … Potential harms also include side effects or complications of treatments. … Screening and Treatment for Depression in Children 3. … Curry’s health service research has focused on the use and cost effectiveness of tobacco cessation treatments … Ophthalmia Neonatorum: Preventive medication for all Newborns a The USPSTF recommends prophylactic ocular topical

79. Final Research Plan: Asymptomatic Carotid Artery Stenosis: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/carotid-artery-stenosis-screening
    November 14, 2019 - Does surgical repair provide incremental benefit beyond current medical treatment for asymptomatic persons … intima-media thickness for CVD risk prediction Comparisons KQs 1, 2: No screening KQ 3: Medical treatment … /usual care (e.g., statins, antiplatelet medications) KQ 4: Medical treatment/usual care or noncomparative

80. Procedure Manual Section 5. Modeling | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-section-5-modeling
    July 05, 2017 - health outcomes that result from alternative interventions for screening, diagnosis, prevention, and treatment … necessary, a decision model can link natural history, population characteristics, and screening or treatment … effectiveness to estimate the relative impact and comparative effectiveness of varying screening or treatment